Skip to content

Clinical Study on Xiaoying Mixture in Treatment of Hashimoto's Thyroiditis

Clinical Study on Xiaoying Mixture in Treatment of Hashimoto's Thyroiditis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005079
Enrollment
Unknown
Registered
2021-07-19
Start date
2021-07-05
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto's Thyroiditis

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Those who meet the diagnostic criteria of Chinese and Western medicine for Hashimoto's thyroiditis. 2. Those who have not taken thyroxine drugs within 3 weeks before seeing a doctor. 3. Free triiodothyronine (FT3), free thyroxine (FT4) and thyroid stimulating hormone (TSH) were normal. 4. Aged between 18-70 years, and the gender is not limited. 5. The patient has no serious heart, liver, renal insufficiency and other systemic infections. 6. The patient has no other genetic diseases, infectious diseases, no malignant tumors, and no severe malnutrition. 7. Patients gave informed consent and participated voluntarily.

Exclusion criteria

Exclusion criteria: 1. Those who have taken immunomodulators or immunosuppressants within 3 months, combined with other thyroid diseases and autoimmune diseases. 2. Patients with combined tumors or other serious diseases with a short expected survival period. 3. Those who have other serious underlying diseases of lung and brain. 4. Pregnant or lactating patients. 5. Alcohol or drug addicts. 6. Patients with psychiatric disorders. 7. Those with allergies. 8. Other cases that violate the research protocol.

Design outcomes

Primary

MeasureTime frame
Total effective rate of efficacy;

Secondary

MeasureTime frame
TCM symptom score;Serum Th1/Th2 related cytokine levels;

Countries

China

Contacts

Public ContactHuang Hechen

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

aloe369@163.com+86 13761603694

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026